Specialties
Anna C. Beck, MD
Assistant Professor
- Division of Surgical Oncology
beckan@surgery.wisc.edu
(608) 263-0736
Education
- MD, Loyola University Chicago Stritch School of Medicine, Chicago, IL
- General Surgery Residency, University of Iowa, Iowa City, IA
- Fellowship, Breast Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
- T32 Research Fellowship, Surgical Oncology, University of Iowa, Iowa City, IA
Clinical Specialties
Dr. Beck specializes in breast surgical oncology with a focus on benign and malignant breast disease, including breast cancer, benign breast disease, high risk breast lesions, and patients at high risk for developing breast cancer. She is certified by the American Board of Surgery.
Dr. Beck provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy.
Research Interests
Dr. Beck’s principal research interests are in breast cancer genomics, specifically seeking to better understand breast cancer risk with the aim of developing ways to better identify individuals who are high risk for the development of breast cancer. She is a member of the Center for Human Genomics and Precision Medicine at UW.
Dr. Beck received a one-year, $25,000 Badger Challenge Award. Read more here.
Recent Publications
Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer.
Chang J, Alzayadneh EM, Rajan A, Tran A, Weigel RJ, Beck AC
Ann Surg Oncol 2025 Apr 11;
[PubMed ID: 40214912]ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
Tran A, Weigel RJ, Beck AC
Am J Surg 2024 Mar; 229: 106-110
[PubMed ID: 37968147]Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
Beck AC, Bayard S, Plitas G, Sevilimedu V, Kuba MG, Garcia P, Morrow M, Tadros AB
Ann Surg Oncol 2023 Oct; 30(10): 6061-6069
[PubMed ID: 37493892]Axillary lymph node dissection: Dead or still alive?
Beck AC, Morrow M
Breast 2023 Jun; 69: 469-475
[PubMed ID: 36702672]A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.
Spanheimer PM, Bashir A, Lorenzen AW, Beck AC, Liao J, Lizarraga IM, Erdahl LM, Sugg SL, Karwal MW, Weigel RJ
Am J Clin Oncol 2021 Sep 01; 44(9): 456-462
[PubMed ID: 34190716]